Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$278,388
-$50,625 QoQ
Shares Held
11,561
-1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#2,188
of 2,821 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Goepper Burkhardt LLC holds $3,500,103 across 6 Drug Manufacturers - General names. PFE ranks #5 (8.0% of the industry book) .
All Filings in PFE
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $278,388 | 11,561 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $329,013 | 11,717 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $310,154 | 12,456 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $398,838 | 15,653 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $436,174 | 17,994 | Shares | Sole | 2025-08-12 | |
| 2023-09-30 | $206,914 | 6,238 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $239,813 | 6,538 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $286,334 | 7,018 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $389,526 | 7,602 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $328,987 | 7,518 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $394,168 | 7,518 | Shares | Sole | 2022-08-26 | |
| 2022-03-31 | $389,206 | 7,518 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $424,156 | 7,183 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $308,854 | 7,181 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $281,207 | 7,181 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $249,624 | 6,890 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $253,031 | 6,874 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||